Exploiting natural riboswitches for aptamer engineering and validation
Nucleic Acids Research · 25.01.2023 · 51 (2) · 966-981
DOI: 10.1093/nar/gkac1218 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 09.01.2023. Verfasst von Michael G Mohsen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT 06511, USA. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Riboswitch, Genetic Engineering. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Howard Hughes Medical Institute, PhRMA Foundation.
Abstract (Originalsprache)
Over the past three decades, researchers have found that some engineered aptamers can be made to work well in test tubes but that these same aptamers might fail to function in cells. To help address this problem, we developed the ‘Graftamer’ approach, an experimental platform that exploits the architecture of a natural riboswitch to enhance in vitro aptamer selection and accelerate in vivo testing. Starting with combinatorial RNA pools that contain structural features of a guanine riboswitch aptamer interspersed with regions of random sequence, we performed multiplexed in vitro selection with a collection of small molecules. This effort yielded aptamers for quinine, guanine, and caffeine that appear to maintain structural features of the natural guanine riboswitch aptamer. Quinine and caffeine aptamers were each grafted onto a natural guanine riboswitch expression platform and reporter gene expression was monitored to determine that these aptamers function in cells. Additionally, we determined the secondary structure features and survival mechanism of a class of RNA sequences that evade the intended selection strategy, providing insight into improving this approach for future efforts. These results demonstrate that the Graftamer strategy described herein represents a convenient and straightforward approach to develop aptamers and validate their in vivo function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT 06511, USA.
- Howard Hughes Medical Institute, Yale University, New Haven, CT 06511, USA.
- Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA.
ORCID-Profile: Michael G Mohsen, Ronald R Breaker
Förderung
- NIGMS NIH HHS
- Howard Hughes Medical Institute
- PhRMA Foundation
- Life Sciences Research Foundation
- National Institutes of Health Chemical Biology
Zitieren
APA
Mohsen, M. G., Midy, M. K., Balaji, A., & Breaker, R. R. (2023). Exploiting natural riboswitches for aptamer engineering and validation. Nucleic Acids Research, 51(2), 966-981. https://doi.org/10.1093/nar/gkac1218
Vancouver
Mohsen MG, Midy MK, Balaji A, Breaker RR. Exploiting natural riboswitches for aptamer engineering and validation. Nucleic Acids Research. 2023;51(2):966-981. doi:10.1093/nar/gkac1218
BibTeX
@article{Mohsen2023,
author = {Mohsen, Michael G and Midy, Matthew K and Balaji, Aparaajita and Breaker, Ronald R},
title = {Exploiting natural riboswitches for aptamer engineering and validation},
journal = {Nucleic Acids Research},
year = {2023},
volume = {51},
number = {2},
pages = {966--981},
doi = {10.1093/nar/gkac1218}
}
EUVIMED